HETEROCYCLIC INHIBITOR OF MEK AND METHOD OF USE THEREOF

PROBLEM TO BE SOLVED: To provide medicaments useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. SOLUTION: There are provided compounds of formula I and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8and R9, W, X and Y a...

Full description

Saved in:
Bibliographic Details
Main Authors WALLACE ELI, YANG HONG WOON, MARLOW ALLISON L, LYSSIKATOS JOSEPH P, SEO JEONGBEOB, BLAKE JIM
Format Patent
LanguageEnglish
Published 08.09.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PROBLEM TO BE SOLVED: To provide medicaments useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. SOLUTION: There are provided compounds of formula I and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8and R9, W, X and Y are as defined in the specification, wherein X is N or CR10, Y is NR3, O, S, S(O), S(O)2, C(O) or CH2, R1, R2R8, R9and R10are independently, hydrogen, hydroxy, halogen, or others. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds are also provided. COPYRIGHT: (C)2011,JPO&INPIT
Bibliography:Application Number: JP20110070629